TEK2day FINANCE Open Terminal →

CONMED Corporation (CNMD)

NYQ · Healthcare · Medical Devices

$34.77 +1.05%

Closing price as of 2026-06-12 · Source: TEK2day Finance

1-Year Price History -36.3% over period
$57$51$44$38$32 2025-062025-092025-122026-032026-06

Key Metrics

Market Cap
$1.05B
Shares Outstanding
30.1M
P/S (TTM)
0.8x
P/E (TTM)
19.6x
Exchange
NYQ
Currency
USD

About CONMED Corporation

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Quarterly Financials

Metric2025-06-302025-09-302025-12-312026-03-31
Revenue342.3M337.9M373.2M317.0M
Gross Profit188.3M166.1M218.3M183.4M
Operating Income38.2M11.9M36.6M25.4M
Net Income21.4M2.9M16.7M13.8M
Diluted EPS$0.69$0.09$0.54$0.45

Annual Financials

Metric2022-12-312023-12-312024-12-312025-12-31
Revenue1.0B1.2B1.3B1.4B
Gross Profit571.2M676.2M733.0M750.5M
Operating Income70.1M120.6M200.3M102.6M
Net Income-80.6M64.5M132.4M47.1M
Diluted EPS$-2.68$2.04$4.25$1.51
Want live quotes, estimates, SEC filings, and CEO analytics for CNMD?
The free TEK2day terminal runs in your browser — type /CNMD to get started.
Open CNMD in the Terminal →